SCHEMBL8338293

SCHEMBL8338293

Cc1nnccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29614351 1.00
Hydrochloric Acid SCHEMBL30852195 0.97
SCHEMBL29479476 0.72
SCHEMBL423090 0.72
SCHEMBL29770643 0.72
Ammonia Solution, Strong SCHEMBL18227036 0.70
Ammonia Solution, Strong SCHEMBL20338348 0.70
Hydrochloric Acid SCHEMBL28430002 0.70
SCHEMBL2042798 0.70
SCHEMBL28537378 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0072299-B1 4-METHYL-6-PHENYL-PYRIDAZINE DERIVATIVES ACTIVE ON THE CENTRAL NERVOUS SYSTEM SANOFI S.A. (FR) 1986-12-17 EP claimed
WO-2019141980-A1 AGRICULTURAL CHEMICALS GLOBACHEM NV (BE) 2019-07-25 WO disclosed
CN-109790181-A Bridging piperidine derivative 豪夫迈·罗氏有限公司 2019-05-21 CN disclosed
US-20170065575-A1 NAMPT INHIBITORS ABBVIE INC (US) 2017-03-09 US disclosed
US-9434721-B2 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. (US) 2016-09-06 US disclosed
US-20150141398-A1 NAMPT INHIBITORS ABBVIE INC. 2015-05-21 US disclosed
CN-104583194-A Pyridazine and pyridine derivatives as NAMPT inhibitors ABBVIE INC 2015-04-29 CN disclosed
EP-2847181-A1 PYRIDAZINE AND PYRIDINE DERIVATIVES AS NAMPT INHIBITORS AbbVie Inc. (US) 2015-03-18 EP disclosed
US-8975398-B2 NAMPT inhibitors ABBVIE INC. (US) 2015-03-10 US disclosed
US-20140142112-A1 THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN PURDUE PHARMA L.P. (US) 2014-05-22 US disclosed
US-8536177-B2 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. (US) 2013-09-17 US disclosed
US-7994167-B2 Pentafluorosulphanyl-substituted compound and its use for producing medicaments GRUENENTHAL GMBH (DE) 2011-08-09 US disclosed
WO-2011050160-A1 PHARMACEUTICALS, COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BIOGEN IDEC MA INC. (US) 2011-04-28 WO disclosed
CN-101679405-A 2-aminopyridine analogs as glucokinase activators ARRAY BIOPHARMA INC 2010-03-24 CN disclosed
US-7683063-B2 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. (US) 2010-03-23 US disclosed
US-20090137594-A1 Pentafluorosulphanyl-Substituted Compound And Its Use For Producing Medicaments GRUENENTHAL GMGH (DE) 2009-05-28 US disclosed
US-7262194-B2 Therapeutic agents useful for treating pain EURO-CELTIQUE S.A. 2007-08-28 US disclosed
US-20070027159-A1 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. 2007-02-01 US disclosed
WO-2004011441-A1 PYRIDAZINYLPIPERAZINE DERIVATIVES FOR TREATING PAIN EURO-CELTIQUE S.A. (LU) 2004-02-05 WO disclosed
EP-0072299-B1 4-METHYL-6-PHENYL-PYRIDAZINE DERIVATIVES ACTIVE ON THE CENTRAL NERVOUS SYSTEM SANOFI S.A. (FR) 1986-12-17 EP disclosed